Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial

Published:2023-07 Issue:10395 Volume:402 Page:54-61
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Quenby Siobhan,Booth Katie,Hiller Louise,Coomarasamy Arri,de Jong Paulien G,Hamulyák Eva N,Scheres Luuk J,van Haaps Thijs F,Ewington Lauren,Tewary Shreeya,Goddijn Mariëtte,Middeldorp Saskia

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss;Quenby;Lancet,2021

2. Recurrent miscarriage: evidence to accelerate action;Coomarasamy;Lancet,2021

3. Antiphospholipid antibodies prevent extravillous trophoblast differentiation;Quenby;Fertil Steril,2005

4. ESHRE guideline: recurrent pregnancy loss;Bender Atik;Hum Reprod Open,2018

5. ESHRE guideline: recurrent pregnancy loss: an update in 2022;Bender Atik;Hum Reprod Open,2023

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous Thromboembolism;International Encyclopedia of Public Health;2025

2. LMWH prevents thromboinflammation in the placenta via HBEGF-AKT signaling;Blood Advances;2024-09-24

3. Antithrombin testing and treatment in pregnancy: Their real-world relationship to clinical outcomes;Thrombosis Research;2024-09

4. A nomogram and risk stratification to predict subsequent pregnancy loss in patients with recurrent pregnancy loss;Human Reproduction;2024-08-23

5. A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-08-12